J
John W. Kusek
Researcher at National Institutes of Health
Publications - 14
Citations - 12145
John W. Kusek is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Renal function & Kidney disease. The author has an hindex of 14, co-authored 14 publications receiving 12013 citations. Previous affiliations of John W. Kusek include Tufts University.
Papers
More filters
Journal Article
K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification
Andrew S. Levey,Josef Coresh,Kline Bolton,Bruce Culleton,Kathy Schiro Harvey,T. Alp Ikizler,Cynda Ann Johnson,Annamaria T. Kausz,Paul L. Kimmel,John W. Kusek,Adeera Levin,Kenneth L. Minaker,Robert Nelson,Helmut G. Rennke,Michael Steffes,Beth Witten,Ronald J. Hogg,Susan Furth,Kevin V. Lemley,Ronald J. Portman,George Schwartz,Joseph Lau,Ethan M Balk,Ronald D. Perrone,Tauqeer Karim,Lara Rayan,Inas Al-Massry,Priscilla Chew,Brad C. Astor,Deirdre De Vine,Garabed Eknoyan,Nathan W. Levin,Sally Burrows-Hudson,William F. Keane,Alan S. Kliger,Derrick Latos,Donna Mapes,Edith Oberley,Kerry Willis,George R. Bailie,Gavin J. Becker,Jerrilynn Burrowes,David Churchill,Allan J. Collins,William Couser,Dick DeZeeuw,Alan Garber,Thomas Golper,Frank A. Gotch,Antonio M. Gotto,Joel W. Greer,Richard H. Grimm,Ramon G. Hannah,Jaime Herrera Acosta,Ronald J. Hogg,Lawrence G. Hunsicker,Michael J. Klag,Saulo Klahr,Caya Lewis,Edmund G. Lowrie,Arthur J. Matas,Sally McCulloch,Maureen Michael,Joseph V. Nally,John M. Newmann,Allen R. Nissenson,Keith Norris,William F. Owen,Thakor G. Patel,Glenda Payne,Rosa A. Rivera-Mizzoni,David A. Smith,Robert A. Star,Theodore Steinman,Fernando Valderrábano,John Walls,Jean Pierre Wauters,Nanette Wenger,Josephine P. Briggs +78 more
TL;DR: In the early 1990s, the National Kidney Foundation (K/DOQI) developed a set of clinical practice guidelines to define chronic kidney disease and to classify stages in the progression of kidney disease.
Journal ArticleDOI
Weight Loss to Treat Urinary Incontinence in Overweight and Obese Women
Leslee L. Subak,Rena R. Wing,Delia Smith West,Frank Franklin,Eric Vittinghoff,Jennifer M. Creasman,Holly E. Richter,Deborah Myers,Kathryn L. Burgio,Amy A. Gorin,Judith Macer,John W. Kusek,Deborah Grady +12 more
TL;DR: A 6-month behavioral intervention targeting weight loss reduced the frequency of self-reported urinary-incontinence episodes among overweight and obese women as compared with a control group.
Journal ArticleDOI
A randomized trial of urodynamic testing before stress-incontinence surgery
Charles W. Nager,Linda Brubaker,Heather J. Litman,Halina M. Zyczynski,R. Edward Varner,Cindy L. Amundsen,Larry T. Sirls,Peggy Norton,Amy Arisco,Toby C. Chai,Philippe E. Zimmern,Matthew D. Barber,Kimberly J. Dandreo,Shawn A. Menefee,Kimberly Kenton,Jerry L. Lowder,Holly E. Richter,Salil Khandwala,Ingrid Nygaard,Stephen R. Kraus,Harry W. Johnson,Gary E. Lemack,Marina Mihova,Michael E. Albo,Elizabeth R. Mueller,Gary Sutkin,Tracey Wilson,Yvonne Hsu,Thomas A. Rozanski,Leslie M. Rickey,David D. Rahn,Sharon L. Tennstedt,John W. Kusek,E. Ann Gormley +33 more
TL;DR: For women with uncomplicated, demonstrable stress urinary incontinence, preoperative office evaluation alone was not inferior to evaluation with urodynamic testing for outcomes at 1 year, and these changes did not lead to significant between-group differences in treatment selection or outcomes.
Journal ArticleDOI
Cardiovascular disease risk factors in chronic renal insufficiency.
Mark J. Sarnak,Boris E. Coronado,Tom Greene,Shin Ru Wang,John W. Kusek,Gerald J. Beck,Andrew S. Levey +6 more
TL;DR: Traditional coronary risk factors are highly prevalent in CRI and vary with the level of renal function, however, the coronary point score does not appear to explain the extent of increased CHD risk in ESRD.
Journal ArticleDOI
Homocysteine-Lowering and Cardiovascular Disease Outcomes in Kidney Transplant Recipients: Primary Results From the Folic Acid for Vascular Outcome Reduction in Transplantation Trial
Andrew G. Bostom,Myra A. Carpenter,John W. Kusek,Andrew S. Levey,Lawrence G. Hunsicker,Marc A. Pfeffer,Jacob Selhub,Paul F. Jacques,Edward Cole,Lisa Gravens-Mueller,Andrew A. House,Clifton E. Kew,Joyce L. McKenney,Alvaro Pacheco-Silva,Todd E. Pesavento,John D. Pirsch,Stephen W. Smith,Scott D. Solomon,Matthew R. Weir +18 more
TL;DR: Treatment with a high-dose folic acid, B6, and B12 multivitamin in kidney transplant recipients did not reduce a composite cardiovascular disease outcome, all-cause mortality, or dialysis-dependent kidney failure despite significant reduction in homocysteine level.